AdvaMed called for more breakthrough devices, including diagnostics, to be eligible for the pathway, and for set timelines for national coverage determinations.
Medtech lobby seeks broader device eligibility for CMS’ proposed RAPID pathway
AdvaMed called for more breakthrough devices, including diagnostics, to be eligible for the pathway, and for set timelines for national coverage determinations.